Seer Board of Directors Issues Letter to Shareholders Setting the Record Straight
Seer, Inc. (Nasdaq: SEER) said its board sent a letter to shareholders ahead of the July 28, 2026 annual meeting, urging votes “FOR” its seven director nominees on the BLUE proxy card. The board disputed claims by the Radoff-JEC group, citing lower cash burn (down 36% since 2022), operating expense declines, and pay/independence arguments.
How this was made
The 30-second read
Why it matters
The key tradable element is the governance contest into a fixed-date vote, which can shift expectations for strategy, capital allocation, and board control.
Market read
This is a governance event update that can drive positioning and volatility into the annual meeting vote date.
What to watch
The letter cites cash-burn and expense reductions, but traders may focus on whether any activist group has filed additional disclosures (e.g., proxy materials, 13D/13A) that could change the probability of outcomes before the vote.
Background
Seer is facing a proxy contest where the Radoff-JEC Group is attempting to replace three directors; the board responds with a shareholder letter and recommends voting FOR its BLUE proxy nominees.
Ticker impact
Seer’s board urges shareholders to vote FOR its seven director nominees on the BLUE proxy card ahead of the July 28, 2026 annual meeting.
Moderate, event-driven volatility into the July 28 vote; direction depends on how investors weigh the activist claims versus the board’s rebuttal.
The article is a board letter with specific governance and cash-burn rebuttals, but it does not disclose a new transaction, filing, or definitive strategic change beyond the upcoming vote.
Market effects
Proxy contests in life sciences tools can highlight investor sensitivity to cash burn, path-to-profitability, and governance credibility.
Primarily US small-cap governance sentiment; limited direct regional spillover.
Low, as the dispute is company-specific and tied to a US shareholder vote.
Counterpoint
Investors may view the board’s rebuttal as defensive and still price in activist risk of strategic change, especially if the stock trades at a perceived discount to cash.
Key entities
- public_companySeer, Inc.
Nasdaq-listed proteomics and life sciences tools company whose board is defending against an activist proxy campaign.
- activist_groupRadoff-JEC Group
Activist coalition making claims about Seer’s performance, governance, and cash burn, according to the board letter.
- governance_bodySeer Board of Directors
Recommends shareholders vote FOR seven director nominees on the BLUE proxy card.
